Discovery Laboratories Inc (NASDAQ:DSCO)

0.70
Delayed Data
As of Jul 02
 +0.03 / +4.48%
Today’s Change
0.64
Today|||52-Week Range
2.03
-39.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$60.0M

Company Description

Discovery Laboratories, Inc. is engaged in the manufacture and development of products for infants and respiratory diseases. It focuses on producing surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Its products include SURFAXIN and AFECTAIR. The company was founded on November 6, 1992 and is headquartered in Warrington, PA.

Contact Information

Discovery Laboratories, Inc.
2600 Kelly Road
Warrington Pennsylvania 18976-3622
P:(215) 488-9300
Investor Relations:

Employees

Shareholders

Other institutional34.66%
Mutual fund holders24.30%
Individual stakeholders0.88%

Top Executives

John G. CooperPresident, Chief Executive Officer & Director
John Andrew TattoryChief Financial Officer & Senior Vice President
Robert SegalSenior Vice President-Medical & Scientific Affairs
Mary B. TempletonSecretary, Senior Vice President & General Counsel
Steven G. SimonsonChief Development Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account